Bill
S 1816
Overview: S 1816 is a bill that relates to the definition of blood lead levels.Purpose and Intent: The primary goal of this bill is to update the definition of "blood lead level" u
Overview: S 1816 is a bill that relates to the definition of blood lead levels.
Purpose and Intent: The primary goal of this bill is to update the definition of "blood lead level" used in various state laws and regulations. This change is intended to align the state's standards with the latest scientific evidence and recommendations from public health authorities regarding the health impacts of lead exposure.
Key Provisions:
- Revises the definition of "blood lead level" to be consistent with the Centers for Disease Control and Prevention's (CDC) current reference value of 3.5 micrograms per deciliter
- Requires state agencies to update their regulations and policies to reflect the new blood lead level definition
- Directs the state health department to develop and implement a comprehensive lead poisoning prevention program
Affected Parties and Impacts:
- Children and families, particularly those in high-risk communities, may benefit from the updated blood lead level standards and the state's lead poisoning prevention efforts
- State agencies responsible for public health, environmental protection, and housing will need to adapt their regulations and programs to the new definition
- Healthcare providers may need to adjust their screening and treatment protocols for lead exposure
Procedural and Timeline Considerations:
- The bill has been referred to the Senate Committee on Ways and Means, indicating it is still in the early stages of the legislative process
- If enacted, the state agencies would have a specified timeline to update their regulations and implement the new blood lead level definition
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
